410 related articles for article (PubMed ID: 28518141)
1. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.
Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S
Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated Fibroblast-promoted LncRNA
Zhang H; Hua Y; Jiang Z; Yue J; Shi M; Zhen X; Zhang X; Yang L; Zhou R; Wu S
Clin Cancer Res; 2019 Mar; 25(6):1989-2000. PubMed ID: 30463848
[TBL] [Abstract][Full Text] [Related]
4. Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer.
Yang X; Chen X; Zhang S; Fan W; Zhong C; Liu T; Cheng G; Zhu L; Liu Q; Xi Y; Tan W; Lin D; Wu C
Cell Rep; 2023 Oct; 42(10):113270. PubMed ID: 37851572
[TBL] [Abstract][Full Text] [Related]
5. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
[TBL] [Abstract][Full Text] [Related]
7. Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma.
Zhang H; Luo H; Jiang Z; Yue J; Hou Q; Xie R; Wu S
J Radiat Res; 2016 Jul; 57(4):370-80. PubMed ID: 27125498
[TBL] [Abstract][Full Text] [Related]
8. Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.
Zhang H; Luo H; Hu Z; Peng J; Jiang Z; Song T; Wu B; Yue J; Zhou R; Xie R; Chen T; Wu S
Oncotarget; 2015 Mar; 6(8):6218-34. PubMed ID: 25749038
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance.
Che Y; Wang J; Li Y; Lu Z; Huang J; Sun S; Mao S; Lei Y; Zang R; Sun N; He J
Cell Death Dis; 2018 Jul; 9(7):759. PubMed ID: 29988148
[TBL] [Abstract][Full Text] [Related]
11. LAMC1 upregulation via TGFβ induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-κB-CXCL1-STAT3.
Fang L; Che Y; Zhang C; Huang J; Lei Y; Lu Z; Sun N; He J
Mol Oncol; 2021 Nov; 15(11):3125-3146. PubMed ID: 34218518
[TBL] [Abstract][Full Text] [Related]
12. The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma.
Zhang H; Si J; Yue J; Ma S
J Cancer Res Clin Oncol; 2021 May; 147(5):1275-1286. PubMed ID: 33687564
[TBL] [Abstract][Full Text] [Related]
13. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
[TBL] [Abstract][Full Text] [Related]
14. Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels.
Dong G; Chen Q; Jiang F; Yu D; Mao Q; Xia W; Shi R; Wang J; Xu L
Oncotarget; 2016 Oct; 7(42):68170-68178. PubMed ID: 27626688
[TBL] [Abstract][Full Text] [Related]
15. Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma.
Pan F; Mao H; Bu F; Tong X; Li J; Zhang S; Liu X; Wang L; Wu L; Chen R; Wei H; Li B; Li C; Yang Y; Steer CJ; Zhao J; Guo Y
Oncotarget; 2017 Jan; 8(4):5735-5752. PubMed ID: 27974696
[TBL] [Abstract][Full Text] [Related]
16. Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
Miyako S; Koma YI; Nakanishi T; Tsukamoto S; Yamanaka K; Ishihara N; Azumi Y; Urakami S; Shimizu M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2024 May; 194(5):828-848. PubMed ID: 38320632
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
[TBL] [Abstract][Full Text] [Related]
18. PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.
Park M; Yoon HJ; Kang MC; Kwon J; Lee HW
Tumour Biol; 2016 Oct; 37(10):14217-14224. PubMed ID: 27557627
[TBL] [Abstract][Full Text] [Related]
19. Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.
Wu H; Yu J; Kong D; Xu Y; Zhang Z; Shui J; Li Z; Luo H; Wang K
Int J Oncol; 2019 Dec; 55(6):1237-1248. PubMed ID: 31638164
[TBL] [Abstract][Full Text] [Related]
20. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X
Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
